Recombinant DNA Expert Witnesses
Recombinant DNA disputes in complex commercial litigation typically center on patent validity, licensing, and regulatory questions involving genetically engineered organisms and gene expression systems, arising when companies disagree over whether a claimed recombinant DNA technology is novel, whether licensed genetic engineering tools were used as permitted, or whether disclosed research data support a patent or regulatory claim. These disputes surface in biotechnology patent litigation over gene cloning, recombinant protein expression, and genetic engineering methods, in licensing disputes over the scope of permitted use for recombinant DNA research tools and expression systems, and in disputes over whether preclinical research data accurately support a company's scientific or regulatory representations. Because recombinant DNA techniques are technical enough that reasonable molecular biologists can characterize the same experimental data differently, the central issue is typically whether the underlying recombinant DNA evidence supports the scientific, patent, or regulatory position a party has taken.
A recombinant DNA expert helps attorneys evaluate that evidence by applying accepted genetic engineering and molecular biology methods to the technology at issue. That might mean assessing whether prior art recombinant DNA research anticipates or renders obvious a claimed gene cloning or expression method, evaluating whether a licensee's use of a recombinant DNA research tool or expression system stayed within the scope of a license agreement, or analyzing whether preclinical data support a company's scientific claims about a recombinant product. This analysis supports positions on patent validity, breach of license terms, and regulatory compliance, giving attorneys a scientifically grounded basis for litigation strategy.
Recombinant DNA cases benefit from experts whose specific research background, whether gene cloning and expression, genetic engineering, or recombinant protein production, matches the precise technology at issue rather than recombinant DNA in general terms. Round Table Group's recombinant DNA network includes molecular biologists and biomedical researchers with published work spanning gene cloning, protein expression, and genetic engineering, several of whom have testified in patent and licensing matters. With more than 75,000 expert searches completed for litigators, we help attorneys match a case's specific recombinant DNA question to an expert whose scientific credentials will withstand scrutiny. Let us help you find the right recombinant DNA expert for your case by calling us at (202) 908-4500.